vs

Side-by-side financial comparison of Fortress Biotech, Inc. (FBIO) and OHIO VALLEY BANC CORP (OVBC). Click either name above to swap in a different company.

OHIO VALLEY BANC CORP is the larger business by last-quarter revenue ($16.2M vs $16.1M, roughly 1.0× Fortress Biotech, Inc.). OHIO VALLEY BANC CORP runs the higher net margin — 24.4% vs -24.5%, a 48.9% gap on every dollar of revenue. On growth, Fortress Biotech, Inc. posted the faster year-over-year revenue change (6.3% vs -4.6%). Over the past eight quarters, Fortress Biotech, Inc.'s revenue compounded faster (11.0% CAGR vs 4.3%).

Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida.

Valley National Bank of Arizona was a bank based in Phoenix, Arizona, founded in 1900 and acquired by Bank One in 1992. The bank was one of Arizona's leading financial institutions during the 20th century and the last major independent bank in Arizona at the time of its acquisition.

FBIO vs OVBC — Head-to-Head

Bigger by revenue
OVBC
OVBC
1.0× larger
OVBC
$16.2M
$16.1M
FBIO
Growing faster (revenue YoY)
FBIO
FBIO
+10.9% gap
FBIO
6.3%
-4.6%
OVBC
Higher net margin
OVBC
OVBC
48.9% more per $
OVBC
24.4%
-24.5%
FBIO
Faster 2-yr revenue CAGR
FBIO
FBIO
Annualised
FBIO
11.0%
4.3%
OVBC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FBIO
FBIO
OVBC
OVBC
Revenue
$16.1M
$16.2M
Net Profit
$-3.9M
$4.0M
Gross Margin
66.1%
Operating Margin
-28.8%
30.7%
Net Margin
-24.5%
24.4%
Revenue YoY
6.3%
-4.6%
Net Profit YoY
41.8%
57.3%
EPS (diluted)
$-0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FBIO
FBIO
OVBC
OVBC
Q4 25
$16.1M
$16.2M
Q3 25
$17.6M
$16.3M
Q2 25
$16.4M
$17.4M
Q1 25
$13.1M
$16.8M
Q4 24
$15.1M
$17.0M
Q3 24
$14.6M
$15.4M
Q2 24
$14.9M
$14.7M
Q1 24
$13.0M
$14.9M
Net Profit
FBIO
FBIO
OVBC
OVBC
Q4 25
$-3.9M
$4.0M
Q3 25
$5.8M
$3.0M
Q2 25
$15.5M
$4.2M
Q1 25
$-10.6M
$4.4M
Q4 24
$-6.8M
$2.5M
Q3 24
$-12.9M
$2.7M
Q2 24
$-10.9M
$3.0M
Q1 24
$-15.4M
$2.8M
Gross Margin
FBIO
FBIO
OVBC
OVBC
Q4 25
66.1%
Q3 25
67.4%
Q2 25
69.9%
Q1 25
63.5%
Q4 24
69.1%
Q3 24
69.4%
Q2 24
61.6%
Q1 24
53.9%
Operating Margin
FBIO
FBIO
OVBC
OVBC
Q4 25
-28.8%
30.7%
Q3 25
-38.6%
22.9%
Q2 25
-222.2%
29.8%
Q1 25
-169.9%
33.1%
Q4 24
-158.3%
18.1%
Q3 24
-151.0%
21.3%
Q2 24
-186.5%
24.7%
Q1 24
-280.6%
22.8%
Net Margin
FBIO
FBIO
OVBC
OVBC
Q4 25
-24.5%
24.4%
Q3 25
33.2%
18.5%
Q2 25
94.4%
24.2%
Q1 25
-80.6%
26.2%
Q4 24
-44.7%
14.8%
Q3 24
-88.0%
17.6%
Q2 24
-73.5%
20.3%
Q1 24
-118.3%
18.8%
EPS (diluted)
FBIO
FBIO
OVBC
OVBC
Q4 25
$-0.15
Q3 25
$0.11
Q2 25
$0.45
Q1 25
$-0.48
Q4 24
$-0.16
Q3 24
$-0.76
Q2 24
$-0.73
Q1 24
$-1.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FBIO
FBIO
OVBC
OVBC
Cash + ST InvestmentsLiquidity on hand
$79.4M
$45.9M
Total DebtLower is stronger
$52.4M
Stockholders' EquityBook value
$49.9M
$170.3M
Total Assets
$185.5M
$1.6B
Debt / EquityLower = less leverage
1.05×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FBIO
FBIO
OVBC
OVBC
Q4 25
$79.4M
$45.9M
Q3 25
$86.2M
$89.3M
Q2 25
$74.4M
$54.6M
Q1 25
$91.3M
$120.6M
Q4 24
$57.3M
$83.1M
Q3 24
$58.9M
$82.2M
Q2 24
$76.2M
$107.7M
Q1 24
$83.8M
$129.1M
Total Debt
FBIO
FBIO
OVBC
OVBC
Q4 25
$52.4M
Q3 25
$47.8M
Q2 25
$50.0M
Q1 25
$56.4M
Q4 24
$58.0M
Q3 24
$52.5M
Q2 24
$67.0M
Q1 24
$61.4M
Stockholders' Equity
FBIO
FBIO
OVBC
OVBC
Q4 25
$49.9M
$170.3M
Q3 25
$55.9M
$164.4M
Q2 25
$43.9M
$160.8M
Q1 25
$22.3M
$155.7M
Q4 24
$22.7M
$150.3M
Q3 24
$21.2M
$152.2M
Q2 24
$17.9M
$145.8M
Q1 24
$23.0M
$145.8M
Total Assets
FBIO
FBIO
OVBC
OVBC
Q4 25
$185.5M
$1.6B
Q3 25
$181.4M
$1.6B
Q2 25
$159.9M
$1.5B
Q1 25
$178.1M
$1.5B
Q4 24
$144.2M
$1.5B
Q3 24
$127.1M
$1.5B
Q2 24
$145.7M
$1.4B
Q1 24
$164.6M
$1.4B
Debt / Equity
FBIO
FBIO
OVBC
OVBC
Q4 25
1.05×
Q3 25
0.86×
Q2 25
1.14×
Q1 25
2.53×
Q4 24
2.55×
Q3 24
2.48×
Q2 24
3.75×
Q1 24
2.67×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FBIO
FBIO
OVBC
OVBC
Operating Cash FlowLast quarter
$-12.5M
$18.1M
Free Cash FlowOCF − Capex
$17.0M
FCF MarginFCF / Revenue
105.2%
Capex IntensityCapex / Revenue
6.4%
Cash ConversionOCF / Net Profit
4.57×
TTM Free Cash FlowTrailing 4 quarters
$26.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FBIO
FBIO
OVBC
OVBC
Q4 25
$-12.5M
$18.1M
Q3 25
$-6.1M
$5.3M
Q2 25
$-27.6M
$4.5M
Q1 25
$-19.6M
$496.0K
Q4 24
$-12.9M
$13.1M
Q3 24
$-20.1M
$5.6M
Q2 24
$-21.8M
$4.2M
Q1 24
$-25.4M
$928.0K
Free Cash Flow
FBIO
FBIO
OVBC
OVBC
Q4 25
$17.0M
Q3 25
$5.0M
Q2 25
$4.4M
Q1 25
$138.0K
Q4 24
$11.7M
Q3 24
$5.4M
Q2 24
$3.9M
Q1 24
$234.0K
FCF Margin
FBIO
FBIO
OVBC
OVBC
Q4 25
105.2%
Q3 25
30.4%
Q2 25
25.1%
Q1 25
0.8%
Q4 24
68.7%
Q3 24
35.1%
Q2 24
26.3%
Q1 24
1.6%
Capex Intensity
FBIO
FBIO
OVBC
OVBC
Q4 25
6.4%
Q3 25
2.1%
Q2 25
0.6%
Q1 25
2.1%
Q4 24
8.4%
Q3 24
0.0%
1.2%
Q2 24
2.2%
Q1 24
4.7%
Cash Conversion
FBIO
FBIO
OVBC
OVBC
Q4 25
4.57×
Q3 25
-1.04×
1.75×
Q2 25
-1.78×
1.06×
Q1 25
0.11×
Q4 24
5.21×
Q3 24
2.06×
Q2 24
1.41×
Q1 24
0.33×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons